位置:首页 > 蛋白库 > MATRX_SENDZ
MATRX_SENDZ
ID   MATRX_SENDZ             Reviewed;         348 AA.
AC   P06446; P27567; Q91UL5; Q9YIJ5; Q9YIM6; Q9YNG5; Q9YNG6; Q9YNG7; Q9YNG8;
AC   Q9YNG9; Q9YNH0; Q9YZ78;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1988, sequence version 1.
DT   29-SEP-2021, entry version 91.
DE   RecName: Full=Matrix protein;
DE            Short=M protein;
GN   Name=M;
OS   Sendai virus (strain Z) (SeV) (Sendai virus (strain HVJ)).
OC   Viruses; Riboviria; Orthornavirae; Negarnaviricota; Haploviricotina;
OC   Monjiviricetes; Mononegavirales; Paramyxoviridae; Orthoparamyxovirinae;
OC   Respirovirus.
OX   NCBI_TaxID=11198;
OH   NCBI_TaxID=10144; Cavia cutleri (Guinea pig).
OH   NCBI_TaxID=36483; Cricetidae sp. (Hamster).
OH   NCBI_TaxID=10090; Mus musculus (Mouse).
OH   NCBI_TaxID=10116; Rattus norvegicus (Rat).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=6095182; DOI=10.1093/nar/12.21.7965;
RA   Hidaka Y., Kanda T., Iwasaki K., Nomoto A., Shioda T., Shibuta H.;
RT   "Nucleotide sequence of a Sendai virus genome region covering the entire M
RT   gene and the 3' proximal 1013 nucleotides of the F gene.";
RL   Nucleic Acids Res. 12:7965-7973(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Mutant F1-R, and Mutant ts-f1;
RX   PubMed=2161155; DOI=10.1016/0042-6822(90)90040-x;
RA   Middleton Y., Tashiro M., Thai T., Oh J., Seymour J., Pritzer E.,
RA   Klenk H.-D., Rott R., Seto J.T.;
RT   "Nucleotide sequence analyses of the genes encoding the HN, M, NP, P, and L
RT   proteins of two host range mutants of Sendai virus.";
RL   Virology 176:656-657(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Mutant F1-R / T-5 revertant;
RX   PubMed=1651590; DOI=10.1016/0042-6822(91)90839-4;
RA   Tashiro M., James I., Karri S., Wahn K., Tobita K., Klenk H.-D., Rott R.,
RA   Seto J.T.;
RT   "Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai
RT   virus.";
RL   Virology 184:227-234(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Mutant KD-11M, Mutant KD-22M, Mutant KD-32M, Mutant KD-51M, and
RC   Mutant KD-52M;
RX   PubMed=1312267; DOI=10.1016/0042-6822(92)90443-s;
RA   Tashiro M., Seto J.T., Choosakul S., Yamakawa M., Klenk H.-D., Rott R.;
RT   "Budding site of Sendai virus in polarized epithelial cells is one of the
RT   determinants for tropism and pathogenicity in mice.";
RL   Virology 187:413-422(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RC   STRAIN=Mutant BF-13, Mutant BF-132, Mutant BF-53, Mutant BF-82,
RC   Mutant BY-4, Mutant BY-41, Mutant BY-5, and Mutant BY-8;
RX   PubMed=9930191; DOI=10.1007/s007050050465;
RA   Okada H., Seto J.T., McQueen N.L., Klenk H.-D., Rott R., Tashiro M.;
RT   "Determinants of pantropism of the F1-R mutant of Sendai virus: specific
RT   mutations involved are in the F and M genes.";
RL   Arch. Virol. 143:2343-2352(1998).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=6285608; DOI=10.1016/0042-6822(82)90036-8;
RA   Buechi M., Baechi T.;
RT   "Microscopy of internal structures of Sendai virus associated with the
RT   cytoplasmic surface of host membranes.";
RL   Virology 120:349-359(1982).
RN   [7]
RP   PHOSPHORYLATION AT SER-70, AND MUTAGENESIS OF SER-70.
RX   PubMed=9281516; DOI=10.1006/viro.1997.8701;
RA   Sakaguchi T., Kiyotani K., Kato A., Asakawa M., Fujii Y., Nagai Y.,
RA   Yoshida T.;
RT   "Phosphorylation of the Sendai virus M protein is not essential for virus
RT   replication either in vitro or in vivo.";
RL   Virology 235:360-366(1997).
RN   [8]
RP   INTERACTION WITH F AND HN PROTEINS.
RX   PubMed=11040121; DOI=10.1006/viro.2000.0556;
RA   Ali A., Nayak D.P.;
RT   "Assembly of Sendai virus: M protein interacts with F and HN proteins and
RT   with the cytoplasmic tail and transmembrane domain of F protein.";
RL   Virology 276:289-303(2000).
RN   [9]
RP   MUTAGENESIS OF CYS-83; CYS-106; CYS-158; CYS-251 AND CYS-295.
RX   PubMed=11799163; DOI=10.1128/jvi.76.4.1682-1690.2002;
RA   Sakaguchi T., Uchiyama T., Huang C., Fukuhara N., Kiyotani K., Nagai Y.,
RA   Yoshida T.;
RT   "Alteration of Sendai virus morphogenesis and nucleocapsid incorporation
RT   due to mutation of cysteine residues of the matrix protein.";
RL   J. Virol. 76:1682-1690(2002).
RN   [10]
RP   INTERACTION WITH HUMAN ALPHA/BETA TUBULINS.
RX   PubMed=14592411; DOI=10.1016/j.bbrc.2003.09.205;
RA   Ogino T., Iwama M., Ohsawa Y., Mizumoto K.;
RT   "Interaction of cellular tubulin with Sendai virus M protein regulates
RT   transcription of viral genome.";
RL   Biochem. Biophys. Res. Commun. 311:283-293(2003).
RN   [11]
RP   INTERACTION WITH HOST ANP32B.
RX   PubMed=31793855; DOI=10.1099/jgv.0.001362;
RA   Guenther M., Bauer A., Mueller M., Zaeck L., Finke S.;
RT   "Interaction of host cellular factor ANP32B with matrix proteins of
RT   different paramyxoviruses.";
RL   J. Gen. Virol. 101:44-58(2020).
CC   -!- FUNCTION: Plays a crucial role in virion assembly and budding. Forms a
CC       shell at the inner face of the plasma membrane and concentrates the HN
CC       and F glycoproteins. Acts as a negative regulator for transcription and
CC       replication by sticking to the nucleocapsid. This effect might be
CC       regulated by the cytoplasmic interaction with tubulin that dissociates
CC       the M protein from the nucleocapsid.
CC   -!- SUBUNIT: Homomultimer. Binds to the cytoplasmic regions of F and HN
CC       proteins. Interacts with nucleocapsid. Interacts with human alpha-
CC       tubulin and beta-tubulin. Interacts with host ANP32B.
CC       {ECO:0000269|PubMed:11040121, ECO:0000269|PubMed:14592411,
CC       ECO:0000269|PubMed:31793855}.
CC   -!- SUBCELLULAR LOCATION: Virion {ECO:0000305}. Host cytoplasm
CC       {ECO:0000269|PubMed:6285608}. Host cell membrane
CC       {ECO:0000269|PubMed:6285608}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:6285608}; Cytoplasmic side
CC       {ECO:0000269|PubMed:6285608}. Note=During bud formation, associates at
CC       the inner side of the plasma membrane of infected cells.
CC   -!- DOMAIN: Late-budding domains (L domains) are short sequence motifs
CC       essential for viral particle budding. They recruit proteins of the host
CC       ESCRT machinery (Endosomal Sorting Complex Required for Transport) or
CC       ESCRT-associated proteins. The matrix protein contains one L domain: a
CC       YLDL motif (By similarity). {ECO:0000250}.
CC   -!- PTM: A large portion is phosphorylated in the cytoplasm, but not in
CC       virion. However, this phosphorylation is not essential for virus
CC       replication. {ECO:0000269|PubMed:9281516}.
CC   -!- SIMILARITY: Belongs to the morbillivirus/respirovirus/rubulavirus M
CC       protein family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X00087; CAA24949.1; -; Genomic_RNA.
DR   EMBL; M30202; AAB06280.1; -; Genomic_RNA.
DR   EMBL; M30203; AAB06286.1; -; Genomic_RNA.
DR   EMBL; M30204; AAB06198.1; -; Genomic_RNA.
DR   EMBL; M69046; AAB06292.1; -; Genomic_RNA.
DR   EMBL; AF001284; AAC82321.1; -; Genomic_RNA.
DR   EMBL; U86424; AAC82304.1; -; Genomic_DNA.
DR   EMBL; U86425; AAC82305.1; -; Genomic_DNA.
DR   EMBL; U86426; AAC82306.1; -; Genomic_DNA.
DR   EMBL; U86427; AAC82307.1; -; Genomic_DNA.
DR   EMBL; U86428; AAC82308.1; -; Genomic_DNA.
DR   EMBL; U86429; AAC82309.1; -; Genomic_DNA.
DR   EMBL; U86430; AAC82310.1; -; Genomic_DNA.
DR   EMBL; U86431; AAC82311.1; -; Genomic_DNA.
DR   EMBL; U86432; AAC82312.1; -; Genomic_DNA.
DR   EMBL; U86433; AAC82313.1; -; Genomic_DNA.
DR   EMBL; U86434; AAC82314.1; -; Genomic_DNA.
DR   EMBL; U86435; AAC82315.1; -; Genomic_DNA.
DR   EMBL; U86436; AAC82316.1; -; Genomic_DNA.
DR   PIR; A04043; MFNZSV.
DR   SMR; P06446; -.
DR   iPTMnet; P06446; -.
DR   Proteomes; UP000006560; Genome.
DR   Proteomes; UP000110830; Genome.
DR   Proteomes; UP000163956; Genome.
DR   Proteomes; UP000169749; Genome.
DR   Proteomes; UP000181310; Genome.
DR   GO; GO:0030430; C:host cell cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0039660; F:structural constituent of virion; IEA:UniProtKB-KW.
DR   GO; GO:0039702; P:viral budding via host ESCRT complex; IEA:UniProtKB-KW.
DR   Gene3D; 2.70.20.50; -; 1.
DR   Gene3D; 2.70.20.60; -; 1.
DR   InterPro; IPR000982; Matrix.
DR   InterPro; IPR042539; Matrix_C.
DR   InterPro; IPR042540; Matrix_N.
DR   Pfam; PF00661; Matrix; 1.
PE   1: Evidence at protein level;
KW   Host cell membrane; Host cytoplasm; Host membrane; Host-virus interaction;
KW   Membrane; Phosphoprotein; Reference proteome; Viral budding;
KW   Viral budding via the host ESCRT complexes; Viral matrix protein;
KW   Viral release from host cell; Virion.
FT   CHAIN           1..348
FT                   /note="Matrix protein"
FT                   /id="PRO_0000142776"
FT   MOTIF           50..53
FT                   /note="YLDL motif"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         70
FT                   /note="Phosphoserine; by host"
FT                   /evidence="ECO:0000305|PubMed:9281516"
FT   VARIANT         42
FT                   /note="D -> V (in wild-type, Mutant F1-R, Mutant F1-R / T-5
FT                   revertant, Mutant ts-f1, Mutant KD-11M, Mutant KD-22M,
FT                   Mutant KD-32M, Mutant 51M and Mutant 52M)"
FT   VARIANT         128
FT                   /note="D -> G (in Mutant F1-R and Mutant F1-R / T-5
FT                   revertant)"
FT   VARIANT         128
FT                   /note="D -> V (in strain: Mutant BY-5)"
FT   VARIANT         161
FT                   /note="V -> M (in strain: Mutant KD-32M)"
FT   VARIANT         182
FT                   /note="I -> V (in strain: Mutant KD-22M)"
FT   VARIANT         191
FT                   /note="D -> Y (in strain: Mutant KD-32M)"
FT   VARIANT         197
FT                   /note="S -> C (in strain: Mutant KD-22M)"
FT   VARIANT         210
FT                   /note="I -> T (in strain: Mutant F1-R and Mutant F1-R / T-5
FT                   revertant)"
FT   VARIANT         211
FT                   /note="S -> F (in strain: Mutant KD-51M)"
FT   VARIANT         212
FT                   /note="T -> A (in strain: Mutant KD-22M and Mutant KD-51M)"
FT   VARIANT         217
FT                   /note="V -> A (in strain: Mutant KD-52M)"
FT   VARIANT         232..233
FT                   /note="MV -> IL (in strain: Mutant BY-4)"
FT   VARIANT         237
FT                   /note="L -> F (in strain: Mutant BY-4, Mutant BF-13 and
FT                   Mutant BY-41)"
FT   VARIANT         237
FT                   /note="L -> M (in strain: Mutant KD-11M)"
FT   VARIANT         240..241
FT                   /note="RK -> SL (in strain: Mutant KD-11M)"
FT   VARIANT         253
FT                   /note="S -> C (in strain: Mutant KD-11M)"
FT   VARIANT         264..267
FT                   /note="LGLI -> VGFV (in strain: Mutant BY-5)"
FT   VARIANT         277
FT                   /note="N -> I (in strain: wild-type, Mutant F1-R, Mutant
FT                   F1-R / T-5 revertant, Mutant ts-f1, Mutant BY-4, Mutant BY-
FT                   8, Mutant BY-13, Mutant BF-41, Mutant BF-53, Mutant BF-82,
FT                   Mutant BF-132, Mutant KD-22M, Mutant KD-32M, Mutant KD-51
FT                   and Mutant KD-52M)"
FT   VARIANT         277
FT                   /note="N -> L (in strain: Mutant BY-5)"
FT   VARIANT         279
FT                   /note="T -> R (in strain: Mutant BY-5)"
FT   VARIANT         294
FT                   /note="V -> L (in strain: Mutant KD-52M)"
FT   MUTAGEN         70
FT                   /note="S->A: Complete loss of phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:9281516"
FT   MUTAGEN         83
FT                   /note="C->S: Smaller viral particles."
FT                   /evidence="ECO:0000269|PubMed:11799163"
FT   MUTAGEN         106
FT                   /note="C->S: Smaller viral particles."
FT                   /evidence="ECO:0000269|PubMed:11799163"
FT   MUTAGEN         158
FT                   /note="C->S: Complete loss of viral infectivity."
FT                   /evidence="ECO:0000269|PubMed:11799163"
FT   MUTAGEN         251
FT                   /note="C->S: Complete loss of viral infectivity."
FT                   /evidence="ECO:0000269|PubMed:11799163"
FT   MUTAGEN         295
FT                   /note="C->A,G,S: Larger viral particles."
FT                   /evidence="ECO:0000269|PubMed:11799163"
SQ   SEQUENCE   348 AA;  38557 MW;  367C3CAA6C4365CF CRC64;
     MADIYRFPKF SYEDNGTVEP LPLRTGPDKK AIPHIRIVKV GDPPKHGVRY LDLLLLGFFE
     TPKQTTNLGS VSDLTEPTSY SICGSGSLPI GVAKYYGTDQ ELLKACTDLR ITVRRTVRAG
     EMIVYMVDSI GAPLLPWSGR LRQGMIFNAN KVALAPQCLP VDKDIRLRVV FVNGTSLGAI
     TIAKIPKTLA DLALPNSISV NLLVTLKTGI STEQKGVLPV LDDQGEKKLN FMVHLGLIRR
     KVGKIYSVEY CKSKIERMRL IFSLGLIGGI SFHVQVNGTL SKTFMSQLAW KRAVCFPLMD
     VNPHMNMVIW AASVEITGVD AVFQPAIPRD FRYYPNVVAK NIGRIRKL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024